Bruker Launches Molecular Phenomics Research Tool for Long COVID Multi-Organ Risk Assessment
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Read MorePosted by Andy Lundin | Oct 27, 2022 | Covid 19, Research |
Bruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Read MorePosted by Chris Wolski | Oct 27, 2022 | Digital Pathology |
Digital innovations are shifting the role of laboratory medicine and represent a new paradigm in standard of care.
Read MorePosted by Andy Lundin | Oct 25, 2022 | Infectious Diseases |
Researchers from UVA have been selected to help establish a national pathogen genomics surveillance network.
Read MorePosted by Andy Lundin | Oct 20, 2022 | Covid 19, Rapid Assays |
A new study demonstrated how rapid antigen test can be used to triage healthcare workers for returning to work during staffing shortages.
Read MorePosted by Andy Lundin | Oct 19, 2022 | Covid 19, Rapid Assays |
An artificial intelligence app designed to read COVID-19 lateral flow tests helped to reduce false results in a new trial.
Read More